Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Long-term follow-up of the West of Scotland Coronary Prevention Study.

Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM; West of Scotland Coronary Prevention Study Group.

N Engl J Med. 2007 Oct 11;357(15):1477-86.

2.

Effect of pravastatin on cardiovascular events in people with chronic kidney disease.

Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M.

Circulation. 2004 Sep 21;110(12):1557-63. Epub 2004 Sep 13. Review.

3.

[Pravastatin and acetylsalycilic acid fixed-combination: a strategy to improve cardiovascular outcomes].

Hennekens C.

Am J Cardiovasc Drugs. 2007;7 Spec No 1:9-11. Review. French.

PMID:
19839182
4.

Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events.

Arca M, Gaspardone A.

Drugs. 2007;67 Suppl 1:29-42. Review.

PMID:
17910519
5.

[LIPID study [Long-term Intervention with Pravastatin in Ischaemic Disease study]].

Homma Y.

Nihon Rinsho. 2001 Mar;59 Suppl 3:416-21. Review. Japanese. No abstract available.

PMID:
11347106
6.

[WOSCOPS [West of Scotland Coronary Prevention Study]].

Furutani N, Tada N.

Nihon Rinsho. 2001 Mar;59 Suppl 3:387-92. Review. Japanese. No abstract available.

PMID:
11347100
7.

Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study.

Hague WE, Simes J, Kirby A, Keech AC, White HD, Hunt D, Nestel PJ, Colquhoun DM, Pater H, Stewart RA, Sullivan DR, Thompson PL, West M, Glasziou PP, Tonkin AM; LIPID study investigators†.

Circulation. 2016 May 10;133(19):1851-60. doi: 10.1161/CIRCULATIONAHA.115.018580. Epub 2016 Mar 25. Review.

8.

Clinical relevance of statins: their role in secondary prevention.

Tonkin AM.

Atheroscler Suppl. 2001 Feb;2(1):21-5. Review.

PMID:
11286152
9.
10.

Pharmacogenomic importance of pravastatin.

Peters B, Maitland-van der Zee AH.

Pharmacogenomics. 2008 Sep;9(9):1207-10. doi: 10.2217/14622416.9.9.1207. Review.

PMID:
18781848
11.

[Hypercholesterolemia in men and women of various age. Part II. The problem of efficacy and safety of statins].

PreobrazhenskiÄ­ DV, Sidorenko BA, Pataraia SA, Vyshinskaia ID, Borisenko OV.

Kardiologiia. 2007;47(11):75-85. Review. Russian.

PMID:
18260968
12.

Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugs.

Shepherd J.

Lancet. 2002 Jun 29;359(9325):2271-3. Review. No abstract available.

PMID:
12103306
13.

Statins and cerebrovascular disease: plaque attack to prevent brain attack.

Mohler ER 3rd, Delanty N, Rader DJ, Raps EC.

Vasc Med. 1999;4(4):269-72. Review.

PMID:
10613632
14.

Supplemental Content

Support Center